share_log

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

6-K:外国发行人报告
美股SEC公告 ·  08/01 07:11
Moomoo AI 已提取核心信息
Alterity Therapeutics Limited, a development stage enterprise, has announced the cessation of 12,000,000 options due to their expiry without exercise or conversion. The options, identified by the ASX security code ATHAAF and expiring on July 31, 2024, had an exercise price of $0.07. This event was officially reported in a Form 6-K filed with the SEC for the month of August 2024. Following the cessation of these securities, Alterity Therapeutics provided an update on its issued capital, which includes various classes of securities and options with different expiry dates and exercise prices. The company's ordinary fully paid shares total 5,320,336,118, and there are several other options with expiry dates ranging from August 2024 to March 2029. The cessation of the ATHAAF options has not involved any consideration from the entity.
Alterity Therapeutics Limited, a development stage enterprise, has announced the cessation of 12,000,000 options due to their expiry without exercise or conversion. The options, identified by the ASX security code ATHAAF and expiring on July 31, 2024, had an exercise price of $0.07. This event was officially reported in a Form 6-K filed with the SEC for the month of August 2024. Following the cessation of these securities, Alterity Therapeutics provided an update on its issued capital, which includes various classes of securities and options with different expiry dates and exercise prices. The company's ordinary fully paid shares total 5,320,336,118, and there are several other options with expiry dates ranging from August 2024 to March 2029. The cessation of the ATHAAF options has not involved any consideration from the entity.
Alterity Therapeutics Limited,一家开发阶段企业,宣布停止了1200万期权,因为它们到期而没有行使或转换。这些期权由ASX安防-半导体代码ATHAAF标识,于2024年7月31日到期,行使价格为0.07美元。此事件已经在提交给SEC的6-k表格中正式报告,时间为2024年8月。在这些证券停止之后,Alterity Therapeutics提供了其已发行的资本更新,其中包括具有不同到期日期和行使价格的各种类别的证券和期权。公司的普通完全支付股份总数为5,320,336,118股,还有若干其他期权,到期日期从2024年8月到2029年3月不等。ATHAAF期权的停止并未涉及该实体的任何考虑。
Alterity Therapeutics Limited,一家开发阶段企业,宣布停止了1200万期权,因为它们到期而没有行使或转换。这些期权由ASX安防-半导体代码ATHAAF标识,于2024年7月31日到期,行使价格为0.07美元。此事件已经在提交给SEC的6-k表格中正式报告,时间为2024年8月。在这些证券停止之后,Alterity Therapeutics提供了其已发行的资本更新,其中包括具有不同到期日期和行使价格的各种类别的证券和期权。公司的普通完全支付股份总数为5,320,336,118股,还有若干其他期权,到期日期从2024年8月到2029年3月不等。ATHAAF期权的停止并未涉及该实体的任何考虑。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息